Menu

Physician Editorial

About Physician Editorial

http://physicianeditorial.com

Posts by Physician Editorial:

Merck Receives FDA Breakthrough Therapy Designation for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

, ,

October 27, 2014 – WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, for the treatment of patients with Epidermal Growth Factor Receptor (EGFR) mutation-negative, and Anaplastic Lymphoma […]

Alexion Launches Every Day with HPP™ Campaign in Support of Hypophosphatasia (HPP) Awareness Week

,

Campaign highlights unique stories and experiences of the HPP community to raise awareness CHESHIRE, Conn. October 27, 2014 –(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the launch of the Every Day with HPP™ campaign in support of the third annual Hypophosphatasia (HPP) Awareness Week Oct. 26–Nov. 1, 2014. HPP Awareness Week is a national public […]

Novartis announces divestiture of influenza vaccines business to CSL for USD 275 million

,

CSL to acquire Novartis influenza vaccines business, including development pipeline, for USD 275 million Announcement follows a transaction announced on April 22, 2014 to divest the non-influenza segments of Novartis Vaccines to GlaxoSmithKline Basel, Switzerland, October 26, 2014 – Novartis today announced it has entered into a definitive agreement to divest its influenza vaccines business […]

Cambia Health Solutions to Launch Health Innovation Collaborative with Inaugural Partners UW Medicine, Regence BlueShield and Qliance

The Seattle-based Facility Will Foster Cross-Industry Collaboration and Advancements in Health Sector on a National Level SEATTLE, OCTOBER 24, 2014 — Cambia Health Solutions announces plans to establish The Cambia Grove, a collaborative facility in Seattle that will serve as a hub to foster innovation and transformation in the health care industry on a national […]

GE Healthcare Life Sciences wins prestigious bioprocessing industry award

,

CHALFONT ST. GILES, UK – 24 October 2014 – GE Healthcare Life Sciences (NYSE:GE) has won a BioProcess International (BPI) industry award for excellence in bioprocessing facility design. The BPI awards, voted for by bioprocess experts and hosted by industry publication BioProcess International, recognize outstanding products, services, partnerships and people that have had the greatest […]

CHMP recommends label update for Esbriet in idiopathic pulmonary fibrosis, strengthening mortality benefit and reinforcing safety profile

, ,

Pooled analysis of ASCEND and two CAPACITY phase III trials show 48 percent reduction in mortality risk at one year1 ASCEND data reinforces the Esbriet safety and efficacy profile1 Approximately 110,000 people in Europe have idiopathic pulmonary fibrosis (IPF), an irreversible, progressive, fatal lung disease2- 5 Only 20–40 percent of IPF patients survive five years […]

Researchers to Present Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at ASN 2014 Annual Meeting

,

CHESHIRE, Conn. October 23, 2014 –(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers will present seven posters detailing findings from clinical studies of Soliris® (eculizumab) in patients with atypical hemolytic uremic syndrome (aHUS) as well as from the Global aHUS Registry at the annual meeting of the American Society of Nephrology (ASN), being held November […]

Roche invests for the future in its Basel site

,

Investments of 3 billion Swiss francs in modern research infrastructure, attractive workplaces and sustainable site development Basel, 22 October 2014 – Today Roche presented development plans for its Basel site. Over the next 10 years, Roche will invest 3 billion Swiss francs in the construction of a new research and development centre for around 1,900 employees, […]

GE leads cloud-based project to improve patient care in Martinique, Guadeloupe and French Guyana

,

Paris, France – 20 October 2014 – GE Healthcare has been chosen by the Medical Imaging Antilles-Guyane (IMAG) purchasing group in France to lead a consortium providing a new cloud imaging platform which will allow vastly improved collaboration between clinicians in Martinique, Guadeloupe and French Guyana. The clinicians will be able to share diagnostic images […]

Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis

,

Biologics License Application (BLA) for secukinumab, a “first-in-class” IL-17A inhibitor, is currently under FDA review with an anticipated action date in early 2015 FDA Advisory Committee recommendation based on efficacy and safety outcomes of 10 Phase II/III clinical studies of secukinumab in moderate-to-severe plaque psoriasis Affecting 7.5 million Americans, psoriasis may negatively impact daily life […]

«‹ 71 72 73 74›»